查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954802

連續性腎臟替代療法 (CRRT) 耗材市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測 (2026–2034)

Continuous Renal Replacement Therapy (CRRT) Consumables Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

連續性腎臟替代療法 (CRRT) 耗材市場成長驅動因子

受急性腎損傷 (AKI) 發病率上升、先進腎臟護理解決方案的廣泛應用以及全球重症監護基礎設施的擴建等因素的推動，全球連續性腎臟替代療法 (CRRT) 耗材市場正經歷穩步增長。 預計2025年市場規模將達到9.1256億美元，從2026年的9.8412億美元增長至2034年的18.6784億美元，預測期內（2026-2034年）複合年增長率（CAGR）為8.34%。

2025年，北美以38.22%的市佔率領先。 這得益於其完善的醫療保健基礎設施以及人們對先進腎臟替代療法的日益關注。 連續性腎臟替代療法（CRRT）耗材包括治療過程中使用的基本醫療產品，例如透析液、置換液、過濾器、抗凝血劑和導管。這些產品對於嚴重腎功能不全患者的治療至關重要，尤其是對於入住加護病房（ICU）的患者。 市場動態 市場驅動因素 急性腎損傷 (AKI) 發生率上升 全球急性腎損傷 (AKI) 病例顯著增加是推動市場成長的主要因素。臨床研究表明，每年有數百萬人遭受 AKI 的困擾，其中低收入和中等收入國家承受的負擔尤其沉重。重症患者通常需要持續性腎臟替代療法 (CRRT) 而非間歇性透析，增加了對血液濾過器、透析液和血路管路等耗材的需求。

此外，產品審批數量的增加和新產品的上市也促進了 CRRT 的應用。 CRRT 設備和一次性產品的技術進步提高了重症監護室 (ICU) 治療的效率和可近性。

市場限制因子

高昂的成本和專業的醫療基礎設施要求

CRRT 手術複雜，需要專業的 ICU 醫療基礎設施和訓練有素的醫護人員。 持續的耗材成本，例如置換液、透析液、過濾器和體外循環迴路，加重了醫療機構的經濟負擔。

在發展中國家，熟練醫護人員短缺和高昂的手術費用阻礙了CRRT的普及。一次CRRT治療費用高達數百美元，在資源匱乏的環境中難以負擔。

市場機會

轉向基於價值的腎臟護理模式

醫院擴大採用以價值為導向的護理模式，專注於改善患者預後和優化ICU住院時間。這一趨勢推動了對先進、易用且高效的CRRT耗材的需求。

製造商正在研發新一代過濾器和液體管理系統，旨在提高解毒能力、最大限度地減少治療中斷並簡化臨床工作流程。 旨在提升醫療專業人員專業技能的數位整合工具和培訓工具也正在實施中。

市場挑戰

缺乏標準化治療方案

與傳統透析不同，CRRT 的治療方案在劑量、治療選擇和液體成分方面因機構而異。這種全球標準化的缺失使產品設計複雜化，並延緩了監管批准。它也會使治療效果的評估和臨床試驗的標準化更加困難，可能阻礙其更廣泛的應用。

市場趨勢

技術進步與數位化整合

CRRT 耗材市場正受益於自動化和數位化醫療的整合。具有追蹤功能的智慧耗材能夠即時監測治療參數和使用情況。 製造商正致力於開發能夠簡化治療流程並提高安全性的系統。

醫院與供應商之間建立策略夥伴關係，進行批量採購，以及採用訂閱式耗材供應模式，也正在成為成本管理策略。

細分市場分析

依類型

  • 置換液（主要細分市場）

該細分市場佔最大的市場佔有率，預計將保持最高的複合年增長率。置換液對於在連續性腎臟替代療法 (CRRT) 期間維持體液和電解質平衡至關重要。敗血症相關急性腎損傷 (AKI) 和多重器官衰竭病例的增加正在推動需求成長。

  • 透析液（成長第二快的細分市場）
  • 過濾器
  • 導管
  • 其他

全球 CRRT 手術數量的增加正在增強所有耗材類別的需求。

依治療方式

  • 連續性靜脈-靜脈血液透析濾過（CVVHDF）－佔比最大

CVVHDF結合了擴散和對流機制，以實現全面的溶質清除。 它廣泛用於治療代謝紊亂嚴重的危重患者。

  • 連續性靜脈-靜脈血液濾過 (CVVH) - 市佔率第二
  • 連續性靜脈-靜脈血液透析 (CVVHD)
  • 慢速連續性超濾 (SCUF)

由於其卓越的運作效率和臨床療效，CVVHDF 仍然是首選的治療方法。

區域展望

北美

北美將在 2025 年以 38.22% 的市佔率引領全球市場。由於完善的重症監護室 (ICU) 基礎設施、有利的報銷政策以及腎臟護理意識的不斷提高，該地區市場規模在 2026 年將達到 3.3072 億美元。政府措施和人力資源發展計劃正在進一步推動該地區的成長。

歐洲

歐洲在2024年佔了相當大的市場佔有率，預計到2034年將保持穩定成長。強勁的研究投入、人口老化以及腎臟疾病盛行率的上升是主要的成長驅動因素。

亞太地區

預計亞太地區在預測期內將達到最高的複合年增長率。快速老化和腎臟疾病發病率的上升正在推動中國和印度等國家對連續性腎臟替代療法（CRRT）的需求。

拉丁美洲、中東和非洲

由於腎臟照護的投資增加，拉丁美洲正經歷溫和成長。 同時，在中東和非洲，在重症監護設施的改善和對先進腎臟治療方法的認識提高的推動下，該地區正經歷溫和擴張。

目錄

第一章 引言

第二章 摘要整理

第三章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章 主要發現

  • 主要國家末期腎病患病率
  • 主要公司新產品發布
  • 產業主要發展動態（併購、合作等）
  • 腎臟替代療法技術進步

第五章 全球持續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測 - 依類型劃分
    • 透析液
    • 置換液
    • 濾鏡
    • 導管
    • 其他
  • 市場分析、洞察與預測 - 依模式劃分
    • 慢速連續超濾 (SCUF)
    • 連續慢速血液濾過 (CVVH)
    • 連續性慢速血液透析 (CVVHD)
    • 連續慢速血液透析濾過 (CVVHDF)
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美連續性腎臟替代療法市場分析、洞察與預測持續性腎臟替代療法 (CRRT) 耗材市場 (2021-2034)

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家/地區

第七章：亞太地區持續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測 (2021-2034)

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 其他亞太地區

第八章：拉丁美洲持續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第九章 中東和非洲連續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 其他中東和非洲國家

第10章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 企業簡介
    • Baxter
    • B Braun SE
    • Fresenius Medical Care AG &Co. KGaA
    • Asahi Kasei Medical Co., Ltd.(Asahi Kasei Corporation)
    • NIPRO
    • TORAY MEDICAL CO, LTD.(TORAY INDUSTRIES, INC.)
    • Nikkiso Co., Ltd.
    • Medtronic
    • Other Prominent Players
Product Code: FBI113670

Growth Factors of Continuous Renal Replacement Therapy (CRRT) consumables Market

The global Continuous Renal Replacement Therapy (CRRT) consumables market is witnessing steady growth due to the increasing prevalence of acute kidney injury (AKI), rising adoption of advanced renal care solutions, and expanding intensive care infrastructure worldwide. The market was valued at USD 912.56 million in 2025 and is projected to grow from USD 984.12 million in 2026 to USD 1,867.84 million by 2034, registering a CAGR of 8.34% during the forecast period (2026-2034).

In 2025, North America dominated the market with a 38.22% share, supported by strong healthcare infrastructure and growing awareness regarding advanced kidney replacement therapies.

CRRT consumables include essential medical products such as dialysates, replacement fluids, filters, anticoagulants, and catheters used during continuous renal replacement therapy. These products are critical in managing patients with severe kidney dysfunction, particularly those admitted to intensive care units (ICUs).

Market Dynamics

Market Drivers

Increasing Incidence of Acute Kidney Injury (AKI)

A significant rise in acute kidney injury cases globally is a key growth driver. According to clinical findings, millions of individuals suffer from AKI annually, with a high burden in low- and middle-income countries. Critically ill patients often require continuous renal replacement therapy rather than intermittent dialysis, thereby increasing demand for consumables such as hemofilters, dialysate fluids, and bloodline sets.

Additionally, growing product approvals and launches are boosting adoption. Technological advancements in CRRT machines and disposables are making therapy more efficient and accessible in ICUs.

Market Restraints

High Cost and Specialized Infrastructure Requirements

CRRT procedures are complex and require specialized ICU infrastructure and trained healthcare professionals. The recurring cost of consumables-including replacement fluids, dialysates, filters, and extracorporeal circuits-adds to the financial burden on healthcare facilities.

In developing economies, limited availability of skilled staff and high procedural costs restrict widespread adoption. A single CRRT session can cost several hundred dollars, limiting affordability in resource-constrained settings.

Market Opportunities

Shift Toward Value-Based Renal Care

Hospitals are increasingly adopting value-based care models focused on improving patient outcomes while optimizing ICU stays. This trend is generating demand for advanced, easy-to-use, and efficient CRRT consumables.

Manufacturers are introducing next-generation filters and fluid management systems designed to enhance toxin removal, minimize therapy interruptions, and simplify clinical workflows. Digital integration and training tools are also being implemented to improve healthcare professional expertise.

Market Challenges

Lack of Standardized Treatment Protocols

Unlike conventional dialysis, CRRT practices vary significantly across institutions in terms of dosing, modality selection, and fluid composition. This lack of global standardization complicates product design and slows regulatory approvals. It also makes outcome measurement and clinical trial standardization more challenging, potentially hindering broader adoption.

Market Trends

Technological Advancements and Digital Integration

The CRRT consumables market is benefiting from automation and digital health integration. Smart consumables with tracking capabilities allow real-time monitoring of therapy parameters and usage. Manufacturers are focusing on systems that simplify therapy delivery and improve safety.

Strategic partnerships between hospitals and suppliers for bulk procurement and subscription-based consumable supply models are also emerging as cost-control strategies.

Segmentation Analysis

By Type

  • Replacement Solutions (Dominant Segment)

This segment holds the largest market share and is expected to maintain the highest CAGR. Replacement solutions are critical for maintaining fluid and electrolyte balance during CRRT. Increasing cases of sepsis-related AKI and multi-organ failure are driving demand.

  • Dialysates (Second-Fastest Growing)
  • Filters
  • Catheters
  • Others

The rising number of CRRT procedures globally is strengthening demand across all consumable categories.

By Modality

  • Continuous Venovenous Hemodiafiltration (CVVHDF) - Largest Share

CVVHDF combines diffusion and convection mechanisms, offering comprehensive solute clearance. It is widely used for critically ill patients with complex metabolic imbalances.

  • Continuous Venovenous Hemofiltration (CVVH) - Second Leading
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Slow Continuous Ultrafiltration (SCUF)

CVVHDF remains the preferred modality due to its superior operational efficiency and clinical effectiveness.

Regional Outlook

North America

North America led the global market in 2025 with a 38.22% share. The regional market reached USD 330.72 million in 2026, supported by strong ICU infrastructure, favorable reimbursement policies, and growing awareness about renal care. Government initiatives and workforce development programs are further boosting regional growth.

Europe

Europe held a substantial share in 2024 and is expected to show steady growth through 2034. Strong research initiatives, an aging population, and increasing kidney disease prevalence are key growth contributors.

Asia Pacific

Asia Pacific is projected to register the highest CAGR during the forecast period. The rapidly aging population and increasing incidence of kidney disorders are expanding the demand for CRRT procedures in countries such as China and India.

Latin America & Middle East & Africa

Latin America is experiencing gradual growth due to increased investments in renal care. Meanwhile, the Middle East & Africa region is witnessing moderate expansion driven by improving ICU facilities and awareness regarding advanced renal therapies.

Competitive Landscape

The market is consolidated, with leading players focusing on product innovation, partnerships, and geographic expansion. Major companies include:

  • Baxter
  • B. Braun SE
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Medical Co., Ltd.
  • NIPRO
  • TORAY MEDICAL CO., LTD.
  • Nikkiso Co., Ltd.
  • Medtronic

These companies leverage strong distribution networks, advanced product portfolios, and regulatory approvals to maintain competitive advantages.

Conclusion

The global CRRT consumables market, valued at USD 912.56 million in 2025, is projected to grow to USD 984.12 million in 2026 and reach USD 1,867.84 million by 2034, at a CAGR of 8.34%. Growth is driven by rising acute kidney injury cases, increasing ICU admissions, and technological advancements in renal care solutions. Although high costs and infrastructure challenges persist, ongoing innovations and the global shift toward value-based renal care are expected to sustain long-term market expansion.

Segmentation

By Type

  • Dialysates
  • Replacement Solutions
  • Filters
  • Catheters
  • Others

By Modality

  • Slow Continuous Ultra Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

By Geography

  • North America (By Type, Modality, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Modality, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, Modality, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, Modality, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Modality, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of End Stage Renal Disease, Key Countries
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
  • 4.4. Technological Advancements in Renal Replacement Therapy

5. Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Dialysates
    • 5.1.2. Replacement Solutions
    • 5.1.3. Filters
    • 5.1.4. Catheters
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Modality
    • 5.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 5.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 5.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Dialysates
    • 6.1.2. Replacement Solutions
    • 6.1.3. Filters
    • 6.1.4. Catheters
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Modality
    • 6.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 6.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 6.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 6.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.3.1. U.K.
    • 6.3.2. Germany
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Scandinavia
    • 6.3.7. Rest of Europe

7. Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Dialysates
    • 7.1.2. Replacement Solutions
    • 7.1.3. Filters
    • 7.1.4. Catheters
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Modality
    • 7.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 7.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 7.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 7.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. Japan
    • 7.3.2. China
    • 7.3.3. India
    • 7.3.4. Australia
    • 7.3.5. Southeast Asia
    • 7.3.6. Rest of Asia Pacific

8. Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Dialysates
    • 8.1.2. Replacement Solutions
    • 8.1.3. Filters
    • 8.1.4. Catheters
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Modality
    • 8.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 8.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 8.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 8.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Brazil
    • 8.3.2. Mexico
    • 8.3.3. Rest of Latin America

9. Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Dialysates
    • 9.1.2. Replacement Solutions
    • 9.1.3. Filters
    • 9.1.4. Catheters
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Modality
    • 9.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 9.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 9.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 9.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. GCC
    • 9.3.2. South Africa
    • 9.3.3. Rest of Middle East & Africa

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Baxter
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. B Braun SE
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Fresenius Medical Care AG & Co. KGaA
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. NIPRO
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. TORAY MEDICAL CO, LTD. (TORAY INDUSTRIES, INC.)
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Nikkiso Co., Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Medtronic
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Other Prominent Players

List of Tables

  • Table 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 9: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 12: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 15: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 18: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025 & 2034
  • Figure 4: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Region, 2025 & 2034
  • Figure 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 7: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 8: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 9: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country, 2025
  • Figure 11: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 12: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 13: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 14: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 15: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 19: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 20: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 21: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 24: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 25: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 26: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 27: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 30: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 31: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 32: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 33: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Share (%), By Company, 2025